nodes	percent_of_prediction	percent_of_DWPC	metapath
Lincomycin—Megacolon toxic—Methotrexate—muscle cancer	0.0906	0.0906	CcSEcCtD
Lincomycin—Abdominal distress—Methotrexate—muscle cancer	0.0558	0.0558	CcSEcCtD
Lincomycin—Megacolon—Methotrexate—muscle cancer	0.046	0.046	CcSEcCtD
Lincomycin—Azotaemia—Vincristine—muscle cancer	0.0292	0.0292	CcSEcCtD
Lincomycin—Induration—Etoposide—muscle cancer	0.0282	0.0282	CcSEcCtD
Lincomycin—Anorectal discomfort—Etoposide—muscle cancer	0.0231	0.0231	CcSEcCtD
Lincomycin—Abdominal cramps—Vincristine—muscle cancer	0.0231	0.0231	CcSEcCtD
Lincomycin—Aplastic anaemia—Dactinomycin—muscle cancer	0.0164	0.0164	CcSEcCtD
Lincomycin—Oesophagitis—Dactinomycin—muscle cancer	0.0159	0.0159	CcSEcCtD
Lincomycin—Phlebitis—Dactinomycin—muscle cancer	0.0147	0.0147	CcSEcCtD
Lincomycin—Azotaemia—Methotrexate—muscle cancer	0.0142	0.0142	CcSEcCtD
Lincomycin—Anorectal discomfort—Doxorubicin—muscle cancer	0.012	0.012	CcSEcCtD
Lincomycin—Local reaction—Doxorubicin—muscle cancer	0.0118	0.0118	CcSEcCtD
Lincomycin—Liver function test abnormal—Dactinomycin—muscle cancer	0.0117	0.0117	CcSEcCtD
Lincomycin—Vesiculobullous rash—Doxorubicin—muscle cancer	0.0117	0.0117	CcSEcCtD
Lincomycin—Oesophagitis—Etoposide—muscle cancer	0.0115	0.0115	CcSEcCtD
Lincomycin—Phlebitis—Etoposide—muscle cancer	0.0106	0.0106	CcSEcCtD
Lincomycin—Pancytopenia—Dactinomycin—muscle cancer	0.0104	0.0104	CcSEcCtD
Lincomycin—Neutropenia—Dactinomycin—muscle cancer	0.0102	0.0102	CcSEcCtD
Lincomycin—Stevens-Johnson syndrome—Dactinomycin—muscle cancer	0.00966	0.00966	CcSEcCtD
Lincomycin—Abscess—Methotrexate—muscle cancer	0.00954	0.00954	CcSEcCtD
Lincomycin—Stomatitis—Dactinomycin—muscle cancer	0.0095	0.0095	CcSEcCtD
Lincomycin—Pancytopenia—Vincristine—muscle cancer	0.00927	0.00927	CcSEcCtD
Lincomycin—Neutropenia—Vincristine—muscle cancer	0.00913	0.00913	CcSEcCtD
Lincomycin—Agranulocytosis—Dactinomycin—muscle cancer	0.00909	0.00909	CcSEcCtD
Lincomycin—Proteinuria—Methotrexate—muscle cancer	0.00859	0.00859	CcSEcCtD
Lincomycin—Stomatitis—Vincristine—muscle cancer	0.00849	0.00849	CcSEcCtD
Lincomycin—Protein urine present—Methotrexate—muscle cancer	0.00847	0.00847	CcSEcCtD
Lincomycin—Erythema multiforme—Dactinomycin—muscle cancer	0.00827	0.00827	CcSEcCtD
Lincomycin—Abscess—Doxorubicin—muscle cancer	0.00826	0.00826	CcSEcCtD
Lincomycin—Rash pustular—Doxorubicin—muscle cancer	0.0082	0.0082	CcSEcCtD
Lincomycin—Oliguria—Methotrexate—muscle cancer	0.00819	0.00819	CcSEcCtD
Lincomycin—Glossitis—Methotrexate—muscle cancer	0.00819	0.00819	CcSEcCtD
Lincomycin—Vaginal inflammation—Methotrexate—muscle cancer	0.00755	0.00755	CcSEcCtD
Lincomycin—Pancytopenia—Etoposide—muscle cancer	0.00751	0.00751	CcSEcCtD
Lincomycin—Neutropenia—Etoposide—muscle cancer	0.0074	0.0074	CcSEcCtD
Lincomycin—Vaginal infection—Methotrexate—muscle cancer	0.00713	0.00713	CcSEcCtD
Lincomycin—Oliguria—Doxorubicin—muscle cancer	0.00709	0.00709	CcSEcCtD
Lincomycin—Glossitis—Doxorubicin—muscle cancer	0.00709	0.00709	CcSEcCtD
Lincomycin—Aplastic anaemia—Methotrexate—muscle cancer	0.00709	0.00709	CcSEcCtD
Lincomycin—Stevens-Johnson syndrome—Etoposide—muscle cancer	0.00699	0.00699	CcSEcCtD
Lincomycin—Stomatitis—Etoposide—muscle cancer	0.00687	0.00687	CcSEcCtD
Lincomycin—Jaundice—Etoposide—muscle cancer	0.00687	0.00687	CcSEcCtD
Lincomycin—Leukopenia—Dactinomycin—muscle cancer	0.00682	0.00682	CcSEcCtD
Lincomycin—Agranulocytosis—Etoposide—muscle cancer	0.00658	0.00658	CcSEcCtD
Lincomycin—Vaginal inflammation—Doxorubicin—muscle cancer	0.00654	0.00654	CcSEcCtD
Lincomycin—Thrombophlebitis—Methotrexate—muscle cancer	0.00633	0.00633	CcSEcCtD
Lincomycin—Colitis—Doxorubicin—muscle cancer	0.00628	0.00628	CcSEcCtD
Lincomycin—Vaginal infection—Doxorubicin—muscle cancer	0.00617	0.00617	CcSEcCtD
Lincomycin—Aplastic anaemia—Doxorubicin—muscle cancer	0.00614	0.00614	CcSEcCtD
Lincomycin—Vertigo—Vincristine—muscle cancer	0.00611	0.00611	CcSEcCtD
Lincomycin—Leukopenia—Vincristine—muscle cancer	0.00609	0.00609	CcSEcCtD
Lincomycin—Erythema multiforme—Etoposide—muscle cancer	0.00599	0.00599	CcSEcCtD
Lincomycin—Oesophagitis—Doxorubicin—muscle cancer	0.00597	0.00597	CcSEcCtD
Lincomycin—Anaphylactic shock—Vincristine—muscle cancer	0.00555	0.00555	CcSEcCtD
Lincomycin—Phlebitis—Doxorubicin—muscle cancer	0.00551	0.00551	CcSEcCtD
Lincomycin—Thrombophlebitis—Doxorubicin—muscle cancer	0.00548	0.00548	CcSEcCtD
Lincomycin—Hepatic function abnormal—Doxorubicin—muscle cancer	0.00543	0.00543	CcSEcCtD
Lincomycin—Pain—Dactinomycin—muscle cancer	0.00531	0.00531	CcSEcCtD
Lincomycin—Hypotension—Vincristine—muscle cancer	0.00519	0.00519	CcSEcCtD
Lincomycin—Liver function test abnormal—Methotrexate—muscle cancer	0.00506	0.00506	CcSEcCtD
Lincomycin—Dermatitis bullous—Doxorubicin—muscle cancer	0.00497	0.00497	CcSEcCtD
Lincomycin—Vertigo—Etoposide—muscle cancer	0.00495	0.00495	CcSEcCtD
Lincomycin—Leukopenia—Etoposide—muscle cancer	0.00493	0.00493	CcSEcCtD
Lincomycin—Abdominal pain—Dactinomycin—muscle cancer	0.00491	0.00491	CcSEcCtD
Lincomycin—Body temperature increased—Dactinomycin—muscle cancer	0.00491	0.00491	CcSEcCtD
Lincomycin—Pain—Vincristine—muscle cancer	0.00475	0.00475	CcSEcCtD
Lincomycin—Hypersensitivity—Dactinomycin—muscle cancer	0.00458	0.00458	CcSEcCtD
Lincomycin—Abdominal discomfort—Methotrexate—muscle cancer	0.00454	0.00454	CcSEcCtD
Lincomycin—Pancytopenia—Methotrexate—muscle cancer	0.0045	0.0045	CcSEcCtD
Lincomycin—Anaphylactic shock—Etoposide—muscle cancer	0.0045	0.0045	CcSEcCtD
Lincomycin—Neutropenia—Methotrexate—muscle cancer	0.00443	0.00443	CcSEcCtD
Lincomycin—Abdominal pain—Vincristine—muscle cancer	0.00439	0.00439	CcSEcCtD
Lincomycin—Body temperature increased—Vincristine—muscle cancer	0.00439	0.00439	CcSEcCtD
Lincomycin—Liver function test abnormal—Doxorubicin—muscle cancer	0.00438	0.00438	CcSEcCtD
Lincomycin—Diarrhoea—Dactinomycin—muscle cancer	0.00425	0.00425	CcSEcCtD
Lincomycin—Hypotension—Etoposide—muscle cancer	0.0042	0.0042	CcSEcCtD
Lincomycin—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.00419	0.00419	CcSEcCtD
Lincomycin—Stomatitis—Methotrexate—muscle cancer	0.00412	0.00412	CcSEcCtD
Lincomycin—Hypersensitivity—Vincristine—muscle cancer	0.00409	0.00409	CcSEcCtD
Lincomycin—Vomiting—Dactinomycin—muscle cancer	0.00395	0.00395	CcSEcCtD
Lincomycin—Agranulocytosis—Methotrexate—muscle cancer	0.00394	0.00394	CcSEcCtD
Lincomycin—Rash—Dactinomycin—muscle cancer	0.00392	0.00392	CcSEcCtD
Lincomycin—Pancytopenia—Doxorubicin—muscle cancer	0.0039	0.0039	CcSEcCtD
Lincomycin—Pain—Etoposide—muscle cancer	0.00385	0.00385	CcSEcCtD
Lincomycin—Neutropenia—Doxorubicin—muscle cancer	0.00384	0.00384	CcSEcCtD
Lincomycin—Diarrhoea—Vincristine—muscle cancer	0.0038	0.0038	CcSEcCtD
Lincomycin—Nausea—Dactinomycin—muscle cancer	0.00369	0.00369	CcSEcCtD
Lincomycin—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.00363	0.00363	CcSEcCtD
Lincomycin—Erythema multiforme—Methotrexate—muscle cancer	0.00359	0.00359	CcSEcCtD
Lincomycin—Urticaria—Etoposide—muscle cancer	0.00357	0.00357	CcSEcCtD
Lincomycin—Jaundice—Doxorubicin—muscle cancer	0.00357	0.00357	CcSEcCtD
Lincomycin—Stomatitis—Doxorubicin—muscle cancer	0.00357	0.00357	CcSEcCtD
Lincomycin—Abdominal pain—Etoposide—muscle cancer	0.00356	0.00356	CcSEcCtD
Lincomycin—Body temperature increased—Etoposide—muscle cancer	0.00356	0.00356	CcSEcCtD
Lincomycin—Tinnitus—Methotrexate—muscle cancer	0.00354	0.00354	CcSEcCtD
Lincomycin—Vomiting—Vincristine—muscle cancer	0.00353	0.00353	CcSEcCtD
Lincomycin—Rash—Vincristine—muscle cancer	0.0035	0.0035	CcSEcCtD
Lincomycin—Dermatitis—Vincristine—muscle cancer	0.0035	0.0035	CcSEcCtD
Lincomycin—Agranulocytosis—Doxorubicin—muscle cancer	0.00341	0.00341	CcSEcCtD
Lincomycin—Hypersensitivity—Etoposide—muscle cancer	0.00331	0.00331	CcSEcCtD
Lincomycin—Nausea—Vincristine—muscle cancer	0.0033	0.0033	CcSEcCtD
Lincomycin—Pruritus—Etoposide—muscle cancer	0.00318	0.00318	CcSEcCtD
Lincomycin—Erythema multiforme—Doxorubicin—muscle cancer	0.0031	0.0031	CcSEcCtD
Lincomycin—Diarrhoea—Etoposide—muscle cancer	0.00308	0.00308	CcSEcCtD
Lincomycin—Tinnitus—Doxorubicin—muscle cancer	0.00306	0.00306	CcSEcCtD
Lincomycin—Vertigo—Methotrexate—muscle cancer	0.00297	0.00297	CcSEcCtD
Lincomycin—Leukopenia—Methotrexate—muscle cancer	0.00295	0.00295	CcSEcCtD
Lincomycin—Vomiting—Etoposide—muscle cancer	0.00286	0.00286	CcSEcCtD
Lincomycin—Rash—Etoposide—muscle cancer	0.00284	0.00284	CcSEcCtD
Lincomycin—Dermatitis—Etoposide—muscle cancer	0.00283	0.00283	CcSEcCtD
Lincomycin—Anaphylactic shock—Methotrexate—muscle cancer	0.00269	0.00269	CcSEcCtD
Lincomycin—Nausea—Etoposide—muscle cancer	0.00267	0.00267	CcSEcCtD
Lincomycin—Vertigo—Doxorubicin—muscle cancer	0.00257	0.00257	CcSEcCtD
Lincomycin—Leukopenia—Doxorubicin—muscle cancer	0.00256	0.00256	CcSEcCtD
Lincomycin—Hypotension—Methotrexate—muscle cancer	0.00252	0.00252	CcSEcCtD
Lincomycin—Anaphylactic shock—Doxorubicin—muscle cancer	0.00233	0.00233	CcSEcCtD
Lincomycin—Pain—Methotrexate—muscle cancer	0.0023	0.0023	CcSEcCtD
Lincomycin—Shock—Doxorubicin—muscle cancer	0.00229	0.00229	CcSEcCtD
Lincomycin—Hypotension—Doxorubicin—muscle cancer	0.00218	0.00218	CcSEcCtD
Lincomycin—Urticaria—Methotrexate—muscle cancer	0.00214	0.00214	CcSEcCtD
Lincomycin—Body temperature increased—Methotrexate—muscle cancer	0.00213	0.00213	CcSEcCtD
Lincomycin—Abdominal pain—Methotrexate—muscle cancer	0.00213	0.00213	CcSEcCtD
Lincomycin—Pain—Doxorubicin—muscle cancer	0.00199	0.00199	CcSEcCtD
Lincomycin—Hypersensitivity—Methotrexate—muscle cancer	0.00198	0.00198	CcSEcCtD
Lincomycin—Pruritus—Methotrexate—muscle cancer	0.00191	0.00191	CcSEcCtD
Lincomycin—Urticaria—Doxorubicin—muscle cancer	0.00185	0.00185	CcSEcCtD
Lincomycin—Abdominal pain—Doxorubicin—muscle cancer	0.00184	0.00184	CcSEcCtD
Lincomycin—Body temperature increased—Doxorubicin—muscle cancer	0.00184	0.00184	CcSEcCtD
Lincomycin—Diarrhoea—Methotrexate—muscle cancer	0.00184	0.00184	CcSEcCtD
Lincomycin—Hypersensitivity—Doxorubicin—muscle cancer	0.00172	0.00172	CcSEcCtD
Lincomycin—Vomiting—Methotrexate—muscle cancer	0.00171	0.00171	CcSEcCtD
Lincomycin—Rash—Methotrexate—muscle cancer	0.0017	0.0017	CcSEcCtD
Lincomycin—Dermatitis—Methotrexate—muscle cancer	0.0017	0.0017	CcSEcCtD
Lincomycin—Pruritus—Doxorubicin—muscle cancer	0.00165	0.00165	CcSEcCtD
Lincomycin—Nausea—Methotrexate—muscle cancer	0.0016	0.0016	CcSEcCtD
Lincomycin—Diarrhoea—Doxorubicin—muscle cancer	0.0016	0.0016	CcSEcCtD
Lincomycin—Vomiting—Doxorubicin—muscle cancer	0.00148	0.00148	CcSEcCtD
Lincomycin—Rash—Doxorubicin—muscle cancer	0.00147	0.00147	CcSEcCtD
Lincomycin—Dermatitis—Doxorubicin—muscle cancer	0.00147	0.00147	CcSEcCtD
Lincomycin—Nausea—Doxorubicin—muscle cancer	0.00139	0.00139	CcSEcCtD
